Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 61 to 63 of 63 entries
Sorted by: Best Match Show Resources per page
Thirty-day Results from the ZEPHYR Registry: Outcomes of EVAR Using the Zenith Alpha™ Abdominal Endovascular Graft for the Treatment of AAA in 347 Patients.

Annals of vascular surgery

Hatzl J, Batenburg MVB, Yeung KK, Fioole B, Verhoeven E, Lauwers G, Kölbel T, Wever JJ, Scheinert D, Van den Eynde W, Rouhani G, Mees BME, Vermassen F, Schelzig H, Cuypers PWM, Böckler D.
PMID: 34474131
Ann Vasc Surg. 2021 Aug 30; doi: 10.1016/j.avsg.2021.06.020. Epub 2021 Aug 30.

BACKGROUND: To report technical and clinical 30-day results following treatment with the Zenith Alpha™ abdominal stent graft from the ZEnith alPHa for aneurYsm Repair Registry (ZEPHYR).METHODS: Multicenter, nonrandomized, single arm, core laboratory-controlled, prospective registry collecting data on the Zenith...

Cite
Hatzl J, Batenburg MVB, Yeung KK, et al. Thirty-day Results from the ZEPHYR Registry: Outcomes of EVAR Using the Zenith Alpha™ Abdominal Endovascular Graft for the Treatment of AAA in 347 Patients. Ann Vasc Surg. 2021;doi: 10.1016/j.avsg.2021.06.020.
Hatzl, J., Batenburg, M. V. B., Yeung, K. K., Fioole, B., Verhoeven, E., Lauwers, G., Kölbel, T., Wever, J. J., Scheinert, D., Van den Eynde, W., Rouhani, G., Mees, B. M. E., Vermassen, F., Schelzig, H., Cuypers, P. W. M., Böckler, D. (2021). Thirty-day Results from the ZEPHYR Registry: Outcomes of EVAR Using the Zenith Alpha™ Abdominal Endovascular Graft for the Treatment of AAA in 347 Patients. Annals of vascular surgery, . https://doi.org/10.1016/j.avsg.2021.06.020
Hatzl, Johannes, et al. "Thirty-day Results from the ZEPHYR Registry: Outcomes of EVAR Using the Zenith Alpha™ Abdominal Endovascular Graft for the Treatment of AAA in 347 Patients." Annals of vascular surgery vol. (2021). doi: https://doi.org/10.1016/j.avsg.2021.06.020
Hatzl J, Batenburg MVB, Yeung KK, Fioole B, Verhoeven E, Lauwers G, Kölbel T, Wever JJ, Scheinert D, Van den Eynde W, Rouhani G, Mees BME, Vermassen F, Schelzig H, Cuypers PWM, Böckler D. Thirty-day Results from the ZEPHYR Registry: Outcomes of EVAR Using the Zenith Alpha™ Abdominal Endovascular Graft for the Treatment of AAA in 347 Patients. Ann Vasc Surg. 2021 Aug 30; doi: 10.1016/j.avsg.2021.06.020. Epub 2021 Aug 30. PMID: 34474131.
Copy Download .nbib Format: NLM
A risk score for iliofemoral patients with deep vein thrombosis.

Journal of vascular surgery. Venous and lymphatic disorders

Shekarchian S, Notten P, Barbati ME, Razavi C, Van Laanen J, Nieman F, Razavi MK, Moossdorff W, Mees B, Jalaie H.
PMID: 33894343
J Vasc Surg Venous Lymphat Disord. 2021 Apr 22; doi: 10.1016/j.jvsv.2021.04.007. Epub 2021 Apr 22.

OBJECTIVE: Deep vein thrombosis (DVT) is a common condition with a high risk of post-thrombotic morbidity, especially in patients with a proximal thrombus. Successful iliofemoral clot removal has been shown to decrease the severity of post-thrombotic syndrome. It is...

Cite
Shekarchian S, Notten P, Barbati ME, et al. A risk score for iliofemoral patients with deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2021;doi: 10.1016/j.jvsv.2021.04.007.
Shekarchian, S., Notten, P., Barbati, M. E., Razavi, C., Van Laanen, J., Nieman, F., Razavi, M. K., Moossdorff, W., Mees, B., & Jalaie, H. (2021). A risk score for iliofemoral patients with deep vein thrombosis. Journal of vascular surgery. Venous and lymphatic disorders, . https://doi.org/10.1016/j.jvsv.2021.04.007
Shekarchian, Soroosh, et al. "A risk score for iliofemoral patients with deep vein thrombosis." Journal of vascular surgery. Venous and lymphatic disorders vol. (2021). doi: https://doi.org/10.1016/j.jvsv.2021.04.007
Shekarchian S, Notten P, Barbati ME, Razavi C, Van Laanen J, Nieman F, Razavi MK, Moossdorff W, Mees B, Jalaie H. A risk score for iliofemoral patients with deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2021 Apr 22; doi: 10.1016/j.jvsv.2021.04.007. Epub 2021 Apr 22. PMID: 33894343.
Copy Download .nbib Format: NLM
DEFICIENCY OF MYELOID PHD PROTEINS AGGRAVATES ATHEROGENESIS VIA MACROPHAGE APOPTOSIS AND PARACRINE FIBROTIC SIGNALING: Atherogenic effects of myeloid PHD knockdown.

Cardiovascular research

van Kuijk K, Demandt JAF, Perales-Patón J, Theelen TL, Kuppe C, Marsch E, de Bruijn J, Jin H, Gijbels MJ, Matic L, Mees BME, Reutelingsperger CPM, Hedin U, Biessen EAL, Carmeliet P, Baker AH, Kramann RK, Schurgers LJ, Saez-Rodriguez J, Sluimer JC.
PMID: 33913468
Cardiovasc Res. 2021 Apr 26; doi: 10.1093/cvr/cvab152. Epub 2021 Apr 26.

AIMS: Atherosclerotic plaque hypoxia is detrimental for macrophage function. Prolyl hydroxylases (PHDs) initiate cellular hypoxic responses, possibly influencing macrophage function in plaque hypoxia. Thus, we aimed to elucidate the role of myeloid PHDs in atherosclerosis.METHODS & RESULTS: Myeloid specific...

Cite
van Kuijk K, Demandt JAF, Perales-Patón J, et al. DEFICIENCY OF MYELOID PHD PROTEINS AGGRAVATES ATHEROGENESIS VIA MACROPHAGE APOPTOSIS AND PARACRINE FIBROTIC SIGNALING: Atherogenic effects of myeloid PHD knockdown. Cardiovasc Res. 2021;doi: 10.1093/cvr/cvab152.
van Kuijk, K., Demandt, J. A. F., Perales-Patón, J., Theelen, T. L., Kuppe, C., Marsch, E., de Bruijn, J., Jin, H., Gijbels, M. J., Matic, L., Mees, B. M. E., Reutelingsperger, C. P. M., Hedin, U., Biessen, E. A. L., Carmeliet, P., Baker, A. H., Kramann, R. K., Schurgers, L. J., Saez-Rodriguez, J., & Sluimer, J. C. (2021). DEFICIENCY OF MYELOID PHD PROTEINS AGGRAVATES ATHEROGENESIS VIA MACROPHAGE APOPTOSIS AND PARACRINE FIBROTIC SIGNALING: Atherogenic effects of myeloid PHD knockdown. Cardiovascular research, . https://doi.org/10.1093/cvr/cvab152
van Kuijk, K, et al. "DEFICIENCY OF MYELOID PHD PROTEINS AGGRAVATES ATHEROGENESIS VIA MACROPHAGE APOPTOSIS AND PARACRINE FIBROTIC SIGNALING: Atherogenic effects of myeloid PHD knockdown." Cardiovascular research vol. (2021). doi: https://doi.org/10.1093/cvr/cvab152
van Kuijk K, Demandt JAF, Perales-Patón J, Theelen TL, Kuppe C, Marsch E, de Bruijn J, Jin H, Gijbels MJ, Matic L, Mees BME, Reutelingsperger CPM, Hedin U, Biessen EAL, Carmeliet P, Baker AH, Kramann RK, Schurgers LJ, Saez-Rodriguez J, Sluimer JC. DEFICIENCY OF MYELOID PHD PROTEINS AGGRAVATES ATHEROGENESIS VIA MACROPHAGE APOPTOSIS AND PARACRINE FIBROTIC SIGNALING: Atherogenic effects of myeloid PHD knockdown. Cardiovasc Res. 2021 Apr 26; doi: 10.1093/cvr/cvab152. Epub 2021 Apr 26. PMID: 33913468.
Copy Download .nbib Format: NLM
Showing 61 to 63 of 63 entries